- call +1-201-465-4211
- email sales@mrinsights.biz
An on-body Injector is a small, lightweight delivery system applied to the skin.
Scope of the Report:
The North American region is expected to account for the largest market share in 2018. The large share of this region can be attributed to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases and favorable reimbursement scenario in this region.
The worldwide market for On-body Injectors is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the On-body Injectors in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
BD Medical
Medtronic
Insulet
Sensile Medical
Ypsomed
Enable Injections
Roche
ScPharmaceuticals
SteadyMed
CeQur
Tandem Diabetes Care
Valeritas
SteadyMed Therapeutics
Amgen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Electronical Injectors
Mechanical Injectors
Others
Market Segment by Applications, can be divided into
Immuno-oncology
Diabetes
Cardiovascular Diseases
Others
There are 15 Chapters to deeply display the global On-body Injectors market.
Chapter 1, to describe On-body Injectors Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of On-body Injectors, with sales, revenue, and price of On-body Injectors, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of On-body Injectors, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe On-body Injectors sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 On-body Injectors Introduction
1.2 Market Analysis by Type
1.2.1 Electronical Injectors
1.2.2 Mechanical Injectors
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Immuno-oncology
1.3.2 Diabetes
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BD Medical
2.1.1 Business Overview
2.1.2 On-body Injectors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BD Medical On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Medtronic
2.2.1 Business Overview
2.2.2 On-body Injectors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Medtronic On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Insulet
2.3.1 Business Overview
2.3.2 On-body Injectors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Insulet On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sensile Medical
2.4.1 Business Overview
2.4.2 On-body Injectors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sensile Medical On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Ypsomed
2.5.1 Business Overview
2.5.2 On-body Injectors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Ypsomed On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Enable Injections
2.6.1 Business Overview
2.6.2 On-body Injectors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Enable Injections On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche
2.7.1 Business Overview
2.7.2 On-body Injectors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 ScPharmaceuticals
2.8.1 Business Overview
2.8.2 On-body Injectors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 ScPharmaceuticals On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SteadyMed
2.9.1 Business Overview
2.9.2 On-body Injectors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 SteadyMed On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CeQur
2.10.1 Business Overview
2.10.2 On-body Injectors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 CeQur On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Tandem Diabetes Care
2.11.1 Business Overview
2.11.2 On-body Injectors Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Tandem Diabetes Care On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Valeritas
2.12.1 Business Overview
2.12.2 On-body Injectors Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Valeritas On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 SteadyMed Therapeutics
2.13.1 Business Overview
2.13.2 On-body Injectors Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SteadyMed Therapeutics On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Amgen
2.14.1 Business Overview
2.14.2 On-body Injectors Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Amgen On-body Injectors Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global On-body Injectors Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global On-body Injectors Sales and Market Share by Manufacturer (2016-2017)
3.2 Global On-body Injectors Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 On-body Injectors Manufacturer Market Share in 2017
3.3.2 Top 6 On-body Injectors Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global On-body Injectors Market Analysis by Regions
4.1 Global On-body Injectors Sales, Revenue and Market Share by Regions
4.1.1 Global On-body Injectors Sales and Market Share by Regions (2013-2018)
4.1.2 Global On-body Injectors Revenue and Market Share by Regions (2013-2018)
4.2 North America On-body Injectors Sales and Growth Rate (2013-2018)
4.3 Europe On-body Injectors Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific On-body Injectors Sales and Growth Rate (2013-2018)
4.5 South America On-body Injectors Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa On-body Injectors Sales and Growth Rate (2013-2018)
5 North America On-body Injectors by Countries
5.1 North America On-body Injectors Sales, Revenue and Market Share by Countries
5.1.1 North America On-body Injectors Sales and Market Share by Countries (2013-2018)
5.1.2 North America On-body Injectors Revenue and Market Share by Countries (2013-2018)
5.2 United States On-body Injectors Sales and Growth Rate (2013-2018)
5.3 Canada On-body Injectors Sales and Growth Rate (2013-2018)
5.4 Mexico On-body Injectors Sales and Growth Rate (2013-2018)
6 Europe On-body Injectors by Countries
6.1 Europe On-body Injectors Sales, Revenue and Market Share by Countries
6.1.1 Europe On-body Injectors Sales and Market Share by Countries (2013-2018)
6.1.2 Europe On-body Injectors Revenue and Market Share by Countries (2013-2018)
6.2 Germany On-body Injectors Sales and Growth Rate (2013-2018)
6.3 UK On-body Injectors Sales and Growth Rate (2013-2018)
6.4 France On-body Injectors Sales and Growth Rate (2013-2018)
6.5 Russia On-body Injectors Sales and Growth Rate (2013-2018)
6.6 Italy On-body Injectors Sales and Growth Rate (2013-2018)
7 Asia-Pacific On-body Injectors by Countries
7.1 Asia-Pacific On-body Injectors Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific On-body Injectors Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific On-body Injectors Revenue and Market Share by Countries (2013-2018)
7.2 China On-body Injectors Sales and Growth Rate (2013-2018)
7.3 Japan On-body Injectors Sales and Growth Rate (2013-2018)
7.4 Korea On-body Injectors Sales and Growth Rate (2013-2018)
7.5 India On-body Injectors Sales and Growth Rate (2013-2018)
7.6 Southeast Asia On-body Injectors Sales and Growth Rate (2013-2018)
8 South America On-body Injectors by Countries
8.1 South America On-body Injectors Sales, Revenue and Market Share by Countries
8.1.1 South America On-body Injectors Sales and Market Share by Countries (2013-2018)
8.1.2 South America On-body Injectors Revenue and Market Share by Countries (2013-2018)
8.2 Brazil On-body Injectors Sales and Growth Rate (2013-2018)
8.3 Argentina On-body Injectors Sales and Growth Rate (2013-2018)
8.4 Colombia On-body Injectors Sales and Growth Rate (2013-2018)
9 Middle East and Africa On-body Injectors by Countries
9.1 Middle East and Africa On-body Injectors Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa On-body Injectors Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa On-body Injectors Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia On-body Injectors Sales and Growth Rate (2013-2018)
9.3 UAE On-body Injectors Sales and Growth Rate (2013-2018)
9.4 Egypt On-body Injectors Sales and Growth Rate (2013-2018)
9.5 Nigeria On-body Injectors Sales and Growth Rate (2013-2018)
9.6 South Africa On-body Injectors Sales and Growth Rate (2013-2018)
10 Global On-body Injectors Market Segment by Type
10.1 Global On-body Injectors Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global On-body Injectors Sales and Market Share by Type (2013-2018)
10.1.2 Global On-body Injectors Revenue and Market Share by Type (2013-2018)
10.2 Electronical Injectors Sales Growth and Price
10.2.1 Global Electronical Injectors Sales Growth (2013-2018)
10.2.2 Global Electronical Injectors Price (2013-2018)
10.3 Mechanical Injectors Sales Growth and Price
10.3.1 Global Mechanical Injectors Sales Growth (2013-2018)
10.3.2 Global Mechanical Injectors Price (2013-2018)
10.4 Others Sales Growth and Price
10.4.1 Global Others Sales Growth (2013-2018)
10.4.2 Global Others Price (2013-2018)
11 Global On-body Injectors Market Segment by Application
11.1 Global On-body Injectors Sales Market Share by Application (2013-2018)
11.2 Immuno-oncology Sales Growth (2013-2018)
11.3 Diabetes Sales Growth (2013-2018)
11.4 Cardiovascular Diseases Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 On-body Injectors Market Forecast (2018-2023)
12.1 Global On-body Injectors Sales, Revenue and Growth Rate (2018-2023)
12.2 On-body Injectors Market Forecast by Regions (2018-2023)
12.2.1 North America On-body Injectors Market Forecast (2018-2023)
12.2.2 Europe On-body Injectors Market Forecast (2018-2023)
12.2.3 Asia-Pacific On-body Injectors Market Forecast (2018-2023)
12.2.4 South America On-body Injectors Market Forecast (2018-2023)
12.2.5 Middle East and Africa On-body Injectors Market Forecast (2018-2023)
12.3 On-body Injectors Market Forecast by Type (2018-2023)
12.3.1 Global On-body Injectors Sales Forecast by Type (2018-2023)
12.3.2 Global On-body Injectors Market Share Forecast by Type (2018-2023)
12.4 On-body Injectors Market Forecast by Application (2018-2023)
12.4.1 Global On-body Injectors Sales Forecast by Application (2018-2023)
12.4.2 Global On-body Injectors Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure On-body Injectors Picture
Table Product Specifications of On-body Injectors
Figure Global Sales Market Share of On-body Injectors by Types in 2017
Table
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
